Innoviva (INVA) EBT Margin (2011 - 2026)
Innoviva (INVA) posted EBT Margin of 239.36% for Q1 2026, up 115.19% on a QoQ basis from 1575.3% in Q4 2025, and up 28290.0% year-over-year from N/an in Q1 2025.
Innoviva (INVA) EBT Margin (2011 - 2026) Analysis & Trends
Innoviva's EBT Margin history runs 16 years deep, the most recent figure standing at 239.36% for Q1 2026.
- Quarterly EBT Margin rose 28290.0% year-over-year to 239.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 85.05% (up 10272.0% YoY) and the FY2025 annual result came in at 79.47%, up 7946.0% from the prior year.
- EBT Margin was 239.36% for Q1 2026 at Innoviva, up from 1575.3% in the prior quarter.
- Across five years, EBT Margin topped out at 2227.4% in Q1 2023 and bottomed at 11507.0% in Q4 2023.
- A 5-year average of 507.84% and a median of 59.16% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin plunged 999387 bps — and 2024, when it surged 1024878 bps.
- Innoviva's EBT Margin stood at 1513.13% in 2022, then sank by 660 bps to 11507.0% in 2023, then jumped by 89 bps to 1258.22% in 2024, then retreated by 25 bps to 1575.3% in 2025, then jumped by 115 bps to 239.36% in 2026.
- Business Quant data shows INVA's EBT Margin at 239.36% in Q1 2026, 1575.3% in Q4 2025, and 44.43% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 239.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239.36% |
| Dec 31, 2025 | -1,575.30% |
| Sep 30, 2025 | 44.43% |
| Jun 30, 2025 | 72.39% |
| Mar 31, 2025 | -43.54% |
| Dec 31, 2024 | -1,258.22% |
| Sep 30, 2024 | 4.76% |
| Jun 30, 2024 | -39.32% |
| Mar 31, 2024 | 1,809.30% |
| Dec 31, 2023 | -11,507.00% |
| Sep 30, 2023 | 59.16% |
| Jun 30, 2023 | 205.34% |
| Mar 31, 2023 | 2,227.40% |
| Dec 31, 2022 | -1,513.13% |
| Sep 30, 2022 | 132.43% |
| Jun 30, 2022 | 498.90% |
| Mar 31, 2022 | 2,009.80% |
| Dec 31, 2021 | -4,537.82% |
| Sep 30, 2021 | 136.81% |
| Jun 30, 2021 | 4,973.67% |